#1 Biotech Stock to Own Today

Dear Investor,

On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body.

This revolutionary new kind of treatment will not just change medicine -

It has the potential to eliminate genetic disease from our species.

If that sounds like science fiction, consider this –

• The Nobel Prize Committee is calling it "The Holy Grail of Medicine"
• The Wall Street Journal reports the company is "transforming medicine."
• 60 Minutes reports the company is "revolutionizing the search for new drugs."

Our research proves that anyone who gets in today could turn every $1, 00 into $1.57 million (or more)!

That's only if the company doesn't get taken over for fast 300% gains first.

That's why the biggest drug companies have rushed to invest over a $1 billion in the past year alone -

Juno Pharma invested $700 million.

Glaxo SmithKline invested $350 million.

Johnson and Johnson invested $292 million.

That's on top of the $120 million Bill Gates and Google Ventures already invested into this.

The list goes on and on…

Never before has so much money invested in a new treatment so quickly.

And because of that, it's going to create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars.

Investor's Business Daily estimates the market is worth at least $75 billion market.

But right now, its stock price is just a tiny fraction of that size.

CLICK HERE to see how you can profit from this rare opportunity>>>

Sincerely,

Dylan Jovine
Behind the Markets
"The Buck Stops Here"

---

This email is a paid advertisement. It is for a product or service that is not offered, recommended or endorsed by OptionPub and neither the company nor its affiliates bear responsibility or control over the content of the advertisement and the product or service offered. There is a very high degree of risk involved in trading. Past results are not indicative of future returns. OptionPub and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for any trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. By downloading this book your information may be shared with our educational partners. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of OptionPub may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

---

This email was sent to phanhoa1821960.trader@blogger.com by OptionPub

37 N Orange Ave | Suite 500 | Orlando | FL | 32801
Forward to a friend | Unsubscribe